Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2289]
News [4632]
Articles [192]
Editorials [8]
Conferences [135]
elearning [9]
ESMO 2023: Latest in EGFR Ex20ins advanced NSCLC
Dr Joshua Sabari, Dr Enriqueta Felip and Dr Alex Spira
ESMO 2023: Latest in EGFR Ex20ins advanced NSCLC ( Dr Joshua Sabari, Dr Enriqueta Felip and Dr Alex Spira )
22 Oct 2023
A biomarker led approach to bladder cancer
Prof Andrea Necchi, Dr Guillermo De Velasco, Prof Arlene Siefker-Radtke and Dr...
A biomarker led approach to bladder cancer ( Prof Andrea Necchi, Dr Guillermo De Velasco, Prof Arlene Siefker-Radtke and Dr Yohann Loriot )
22 Oct 2023
Modified radical mastectomy
Dr Abhishek Sharma - TMC, Kolkata
Modified radical mastectomy ( Dr Abhishek Sharma - TMC, Kolkata )
9 Oct 2023
Looking at radioiodine and other radio-labelled metabolites for thyroid cancers
Dr Jayanta Das - Tata Medical Center, Kolkata, India
Looking at radioiodine and other radio-labelled metabolites for thyroid cancers ( Dr Jayanta Das - Tata Medical Center, Kolkata, India )
9 Oct 2023
Early breast cancer: Treatment pattern
Dr Soumen Das - Netaji Subhas Chandra Bose Cancer Hospital, Kolkata, India
Early breast cancer: Treatment pattern ( Dr Soumen Das - Netaji Subhas Chandra Bose Cancer Hospital, Kolkata, India )
9 Oct 2023
Looking at radioiodine and other radio-labelled metabolites for thyroid cancers
Dr Jayanta Das - TMC, Kolkata
Looking at radioiodine and other radio-labelled metabolites for thyroid cancers ( Dr Jayanta Das - TMC, Kolkata )
9 Oct 2023
Locally advanced breast cancer
Dr Rudradeep Banerjee - IPGMER and SSKM Hospital, Kolkata, India
Locally advanced breast cancer ( Dr Rudradeep Banerjee - IPGMER and SSKM Hospital, Kolkata, India )
9 Oct 2023
Cost-benefit analysis of new cancer medicines: The difficult choices of...
Dr Nwamaka Lasebikan, Prof P.G. Roy, Dr Didier Verhoeven
Cost-benefit analysis of new cancer medicines: The difficult choices of governments ( Dr Nwamaka Lasebikan, Prof P.G. Roy, Dr Didier Verhoeven )
8 Oct 2023
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
Dr Gabriele Casirati - Dana-Farber Cancer Institute, Boston, USA
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia ( Dr Gabriele Casirati - Dana-Farber Cancer Institute, Boston, USA )
3 Oct 2023
OncoAlert Round Up for September 15-21, 2023
Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
25 Sep 2023
Osimertinib plus chemotherapy shows superior results versus osimertinib alone...
Prof Pasi Janne - Dana Farber Cancer Institute, Boston, USA
Osimertinib plus chemotherapy shows superior results versus osimertinib alone for EGFR-mutated advanced lung cancer ( Prof Pasi Janne - Dana Farber Cancer Institute, Boston, USA )
21 Sep 2023
OncoAlert Round Up for September 1-7, 2023
Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert Round Up for September 1-7, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
12 Sep 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation